Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2020-07-07 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
PureTech’s Vor Raises $110M Series B Financing
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated July 6/7, 2020. It announces that a company founded by PureTech Health, Vor Biopharma, has raised $110 million in a Series B financing round. This type of announcement, detailing fundraising, capital structure changes, or significant corporate events released via an official news service (RNS), fits best under the 'Capital/Financing Update' category. Although it is distributed via RNS, the core content is a financing announcement, making 'CAP' more specific than the general 'RNS' fallback. The document is substantial (9410 chars) and contains the full details of the financing, not just a notice that a report is attached.
2020-07-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 0567S' and contains the header 'National Storage Mechanism | Additional information'. The content is a 'TR-1: Standard form for notification of major holdings', which details changes in voting rights thresholds crossed by an entity (Jupiter Asset Management Limited/Jupiter Fund Management Plc). This type of mandatory disclosure to a regulatory body (FCA) and subsequent dissemination via the London Stock Exchange's news service (RNS) fits the definition of a regulatory filing. Since 'Major Shareholding Notification' (MRQ) is a specific category for changes in significant share ownership, and this document is a TR-1 form detailing exactly that, MRQ is the most precise classification. Although it is distributed via RNS, the content itself is a specific regulatory report, not just a general announcement of a report's release.
2020-07-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document explicitly starts with 'RNS Number : 0566S' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. Section 2 indicates the reason for notification is related to an acquisition/disposal of voting rights due to a change in ownership structure. This format, the RNS identifier, and the content (reporting changes in major shareholdings) strongly indicate a regulatory filing related to ownership thresholds. This aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-07-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly marked with an 'RNS Number' and states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Total Voting Rights and Share Capital' as of a specific date (30 June 2020), which is a mandatory disclosure under regulatory rules (DTR 5.6.1). While this information relates to share capital changes, the primary function of this short announcement is regulatory dissemination via the RNS system. Since the document is a brief regulatory update disseminated through the RNS service and does not fit neatly into specific categories like DIV, SHA, or DIRS, the most appropriate classification is the general regulatory filing category, RNS.
2020-07-01 English
Karuna Positive FDA End of Phase 2 Meeting
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 8264Q' and concludes with information about RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA). This strongly indicates a regulatory announcement disseminated via the RNS system. The content itself is a press release from PureTech Health plc regarding an update on its founded entity, Karuna, concerning FDA meeting outcomes and future clinical trial plans (Phase 3 initiation). This type of material—a corporate update released through an official regulatory news service—fits best under the general 'Regulatory Filings' category (RNS) as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change announcement. It is a general corporate update disseminated via the regulatory channel.
2020-06-23 English
Akili Gets European Approval to Market EndeavorRx
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated June 23, 2020. It contains an announcement from PureTech Health plc regarding its Founded Entity, Akili, receiving a CE Mark approval for EndeavorRx in Europe. The text structure, including the RNS header, the announcement of a specific corporate event (regulatory approval for a subsidiary's product), and the concluding boilerplate information from RNS (London Stock Exchange's news service), strongly indicates this is a general regulatory news service announcement. Since it is not a full financial report (like 10-K or IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2020-06-23 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.